Evidence map›Paper›PMID 38223926›Full record

ReviewAmerican journal of physiology. Cell physiology2024

Sensational site: the sodium pump ouabain-binding site and its ligands.

Mordecai P Blaustein, John M Hamlyn

Open access · greenAbstract readReview
In one paragraph

Review in American journal of physiology. Cell physiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Steroid hormone ouabain cooperates with NaActa pharmaceutica Sinica. B · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. NaThe Journal of membrane biology · 2026
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Molecules (Basel, Switzerland) · 2025
    Article
  15. Strategies to Develop Na,K-ATPase-α4 Inhibitors as Male Contraceptives.International journal of molecular sciences · 2025
    Article
  16. Reviews in cardiovascular medicine · 2025
    Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Mordecai P BlausteinDepartment of Physiology, University of Maryland School of Medicine, Baltimore, Maryland, United States.ORCID 0000-0002-2926-710X
John M HamlynDepartment of Physiology, University of Maryland School of Medicine, Baltimore, Maryland, United States.ORCID 0000-0001-5875-4807
University of Maryland, Baltimore · US

Funding

Serb Pharmaceuticals/BTG Pharmaceuticals Clinical Trial Contract
6 · The paper itself

Abstract

Cardiotonic steroids (CTS), used by certain insects, toads, and rats for protection from predators, became, thanks to Withering's trailblazing 1785 monograph, the mainstay of heart failure (HF) therapy. In the 1950s and 1960s, we learned that the CTS receptor was part of the sodium pump (NKA) and that the Na

Indexed as

Heart FailureHypertensionAnimalsBinding SitesCalcium SignalingCardiotonic AgentsDigoxinEnzyme InhibitorsHumansLigandsOuabainRatsSodium-Potassium-Exchanging ATPaseCardiotonic AgentsDigoxinEnzyme InhibitorsLigandsOuabainSodium-Potassium-Exchanging ATPasecardiotonic steroidsdigoxinmarinobufageninprotein kinase cascadesignalosome

Identifiers

PMID38223926
PMCPMC11193536
OpenAlexW4390881832

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.